MedPath

To identify and detect the early signs of autism in children using eye-movement patterns

Phase 1
Conditions
Health Condition 1: F840- Autistic disorder
Registration Number
CTRI/2021/03/031840
Lead Sponsor
Department of Science and Technology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Children with a diagnosis of ASD (The diagnosis of ASD would be established base on DSM V criteria and Modified Checklist for Autism (M-CHAT), upon administration of Childhood Autism Rating Scale (CARS).

2.Normal vision and hearing (based on electrophysiological assessment)

Exclusion Criteria

1.High risk factors

2.Siblings with Autism or any other speech and language disorder

3.History of delayed developmental milestones

4.Any neurological issues or history

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1)Interest area dwell time <br/ ><br>2)Interest area dwell time percentage <br/ ><br>3)Interest area fixation percentage <br/ ><br>4)Interest area fixation count <br/ ><br>5)Interest area first fixation duration <br/ ><br>6)Trial dwell time <br/ ><br>7)Trial fixation count <br/ ><br>8)Trial Interest area count <br/ ><br>Timepoint: 1)Interest area dwell time <br/ ><br>2)Interest area dwell time percentage <br/ ><br>3)Interest area fixation percentage <br/ ><br>4)Interest area fixation count <br/ ><br>5)Interest area first fixation duration <br/ ><br>6)Trial dwell time <br/ ><br>7)Trial fixation count <br/ ><br>8)Trial Interest area count <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Sensitivity and specificity of the eye gaze detection paradigmTimepoint: Phase II during follow up after 2 to 21/2 years of first assessment using eye gaze detection paradigm
© Copyright 2025. All Rights Reserved by MedPath